[1]宋进华.乳腺癌的基因治疗与核素靶向治疗[J].国际放射医学核医学杂志,2003,27(6):241-244.
　SONG Jin-hua.Gene therapy and radionuclides targeting therapy in mammary carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(6):241-244.
点击复制

乳腺癌的基因治疗与核素靶向治疗(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
27
期数:
2003年第6期
页码:
241-244
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Gene therapy and radionuclides targeting therapy in mammary carcinoma
作者:
宋进华
210009 南京, 东南大学医学院
Author(s):
SONG Jin-hua
Department of Nuclear Medical Technique, Southeast University, Nanjing 210009, China
关键词:
基因治疗; 靶向治疗; 乳腺癌
Keywords:
gene therapy; targeting therapy; mammary carcinoma
分类号:
R817.5
摘要:
乳腺癌的基因治疗是近年来肿瘤治疗研究的热点,目前处于实验或临床初步应用的基因治疗方法主要有免疫基因治疗、多药耐药基因治疗、反义寡核苷酸治疗、自杀基因治疗等方法,而将基因治疗与射核素相结合的基因靶向近距离放射治疗的方法具有放射性核素与自杀基因对肿瘤细胞的双重杀灭作用,为肿瘤基因治疗开辟了一条崭新的途径,在这一领域进一步研究必将加快基因靶向治疗向临床应用迈进的步伐。
Abstract:
Breast carcinorma’s gene therapy is a hotspot in study of the tumor’s therapy in the recent years. Currently the major therapy methods that in the experimentative and primary clinical application phases include immunological gene therapy, multidrug rssistrance gene therapy, antisense oligonucleotide therapy and suicide gene therapy. The gene targeting brachytherapy, which is combined with gene therapy and radiotherapy has enhanced the killer effects of the suicide gene and nuclide in tumor cells. That has break a new path in tumor’s gene therapy. The further study in this field will step up it’s space to the clinical application.

参考文献/References:

[1] Amornmarn R, Bui MM. Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy[J]. Ann Clin Labo Sci, 2000, 30(1):33-40.
[2] Kurihara T, Brough DE, Kovesdi I, et al. Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antige[J]. Journal Clin Invest,2000, 106(6):763-771.
[3] Indraccolo S, Cola E, Rosato A, et al. Differential effects of angiostatin endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells[J]. Gene Therapy, 2002, 9(13):867-878.
[4] Lichtor T, Moser R, Cohen EP. Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in mice[J]. J Neurosurg, 2001, 94(2):287-292.
[5] Obermiller PS, Tait DL, Holt JT. Gene therapy for carcinoma of the breast:Therapeutic genetic correction strategies[J]. Breast Cancer Res, 2000, 2(1):28-31.
[6] Lesoom, Wood LA, Kim WH, et al. Systemic gene therapy with p53 reduces growth and metastastase so famalignant human breast cancer in nude mice[J]. Hum Gene Ther,1995, 6(4):39-52.
[7] Wang SC, Zhang L, Hortobagyi GN, et al. Targeting HER2:recent developments and future directions for breast cancer patients[J]. Semin Oncol, 2001, 28(6 Supp118):21-29.
[8] Springer CJ, Niculescu-Duvazl I. Prodrug activating systems in suicide gene theraphy[J]. J Clin Inves, 2000, 105(9):1161-1167.
[9] Morimoto J, Otsuki Y. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation[J]. Cancer Gene Ther, 2002, 9(1):16-27.
[10] Grignet-Debrus C, Cool V, Baudson N, et al. The role of cellular-and prodrug-associated factors in the bystander effect induced by the varicella zoster and herpes simplex viral thymidine kinases in suicide gene therapy[J]. Cancer Gene Ther, 2000, 7(11):1456-1468.
[11] Balzarini J, Ostrowski T, Goslinski T, et al. Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines[J]. Gene Ther, 2002, 9(17):1173-1182.
[12] Guha C, Guha U, Tribius S, et al. Antisence ATM gene therapy:as trategy to increase the radios ensitivity of human tumors[J]. Gene Ther, 2000, 7(10):852-858.
[13] Majumdar AS, Zolotorev A, Samuel S, et al. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model[J]. Cancer Gene Ther, 2000,7(7):1086-1099.
[14] Braiden V, Ohtsuru A, Kawashita Y, et al. Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter[J].Hum Gene Ther, 2000, 11(18):2453-2463.
[15] Wu Q, Moyana T, Xiang J. Cancer gene therapy by adenovirus-mediated gene transfer[J]. Cur Gene Ther, 2001,1(1):101-122.
[16] Vlachaki MT, Chhikara M, Aguilar L, et al. Enhanced therapeutic effect of multiple injections of HSV-TK+GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model[J]. Int J Radiat Oncol Biol Phys,2001, 51(4):1008-1017.
[17] Larson SM, Tjuvajev J, Biasberg R. Triumph qver mischance:a role for nuclear medicine in gene theraphy[J]. J Nucl Med, 1997, 38:1230-1233.
[18] Mairs R J, Cunningham SH, Boyd M, et al. Application sof gene transfer to targeted radiotherapy[J]. Curr Pharm Des,2000, 6(14):1419-1432.
[19] Boland A, Ricard M, Opolon P, et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy[J]. Cancer Res, 2000, 60(13):3484-3492.
[20] Larnmering G, Hewit TH. Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization[J]. J Nat Cancer Inst, 2001, 93(12):921-929.
[21] Germann C, Shields AF, Griersion JR, et al. 5 Fluoro 1(2,deoxy 2, fluorobeta Dribofuranosyl) uraciil trapping in morris hepatoma cell sex pressing the herpes simple the herpes simplex virus thymid ine kinase gene[J]. J Nucl Med,1998, 39(8):1418-1423.

相似文献/References:

[1]王华伟,张宇睿,徐文清.线粒体靶向药物的研究进展[J].国际放射医学核医学杂志,2016,40(4):312.[doi:10.3760/cma.j.issn.1673-4114.2016.04.015]
　Wang Huawei,Zhang Yurui,Xu Wenqing.Progress in mitochondrial targeting drug delivery systems[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):312.[doi:10.3760/cma.j.issn.1673-4114.2016.04.015]
[2]储小飞,赵舒怡,樊赛军.肿瘤干细胞与辐射抗性的研究进展[J].国际放射医学核医学杂志,2015,39(5):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
　chu xiaofei,zhao shuyi,fan saijun..advance progress of cancer stem cells and radioresistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
[3]程勇军,赵晋华.东亚钳蝎氯毒素在胶质瘤靶向显像与治疗中的研究进展[J].国际放射医学核医学杂志,2015,39(1):32.[doi:10.3760/cma.j.issn.1673-4114.2015.01.008]
　Cheng Yongjun,Zhao Jinhua.Development of research in targeting image and therapy of gliomas using Buthus martensii Karsch chlorotoxin[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):32.[doi:10.3760/cma.j.issn.1673-4114.2015.01.008]
[4]章文成,杨占山.VEGF的放射生物学特性及其应用[J].国际放射医学核医学杂志,2005,29(1):33.
　ZHANG Wen-cheng,YANG Zhan-shan.The radiation-biological characteristics and application of vascular endothelial growth factor[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):33.
[5]余永利.不摄取131I的甲状腺癌治疗[J].国际放射医学核医学杂志,2005,29(2):57.
　YU Yong-li.Treatment of non-uptaking 131I thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):57.
[6]陈立波,朱瑞森.NIS在肿瘤核素基因显像与治疗中的应用研究[J].国际放射医学核医学杂志,2005,29(2):70.
　CHEN Li-bo,ZHU Rui-sen.Progress of application study on sodium/iodide symporter as a radionuclide imaging and therapeutic gene[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):70.
[7]赵伟,张秀丽.PET报告基因显像研究进展[J].国际放射医学核医学杂志,2005,29(5):238.
　ZHAO Wei,ZHANG Xiu-li.The progress of PET based reporter gene imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):238.
[8]秦丽莉,张春明.单链抗体研究进展及其在医学中的应用[J].国际放射医学核医学杂志,2005,29(6):255.
　QIN Li-li,ZHANG Chun-ming.The research progress and medicine application of the ScFv antibody[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):255.
[9]柳江燕,陈雪红.肿瘤受体显像及介导靶向治疗的研究进展[J].国际放射医学核医学杂志,2005,29(6):258.
　LIU Jiang-yan,CHEN Xue-hong.Advances of tumor receptor imaging and receptor-targeted radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):258.
[10]郑爱青,于金明.对乏氧和射线应答的嵌合性基因启动子的研究进展[J].国际放射医学核医学杂志,2004,28(2):74.
　ZHENG Ai-qing,YU Jin-ming.Development of chimeric gene promoters responsive to hypoxia and ionizing radiation[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(6):74.

备注/Memo

备注/Memo:
收稿日期:2003-05-06
基金项目:国家自然科学基金资助项目(30070229)
作者简介:宋进华(1976-),男,住院医师,硕士研究生,主要从事核素治疗的研究。
更新日期/Last Update: 1900-01-01